ClinicalTrials.Veeva

Menu

Hellenic Registry for cIAIs (HERCO-II)

M

Maximos Frountzas

Status

Completed

Conditions

Intra-abdominal Infection

Study type

Observational

Funder types

Other

Identifiers

NCT05549076
HERCO-II 2022

Details and patient eligibility

About

Complicated Intra-Abdominal Infections (cIAIs) represent an emergent surgical situation which lead to important non trauma-related mortality in several Emergency Surgical Centers worldwide. Their prevalence seemed to be unrelated to age, gender, health status and socioeconomic condition. Early diagnosis, timely septic source control, wide-spectrum antibiotic delivery and resuscitation with fluids and vasoactive agents in critically ill patients are fundamentals for successful cIAIs management. Moreover, septic shock, antibiotic resistant multi-pathogens and comorbidities have been associated with increased morbidity and mortality of cIAIs.

Several international health associations announce updated guidelines for cIAIs management. Nevertheless, such guidelines could not be widely implemented, because of specific features of several healthcare systems worldwide. The aim of the present study is to investigate the prevalence of cIAIs among the Greek health system and the potential association of time interval of septic source control, preoperative resuscitation and multidrug resistant pathogens with morbidity, mortality, ICU stay and length of stay in patients with cIAIs.

Full description

Registry of patients with complicated intra-abdominal infections including:

  • Patient demographics (gender, age, Carlson Comorbidity Index, cancer history/chemotherapy during the last 6 months, health unit stay during the last 6 months)
  • Management (conservative, minimally invasive, surgical)
  • Minimally invasive procedure - type (CT-guided drainage, endoscopic)
  • Surgical procedure - type (open or laparoscopic, day or night, procedure description)
  • Cultures (blood, peritoneal fluid, tissue)
  • Time of diagnosis (respiratory rate, heart rate, systolic blood pressure, lactate acid in blood gases, temperature, white cell count, CRP)
  • Just before procedure (respiratory rate, heart rate, systolic blood pressure, lactate acid in blood gases, vasoactive agent delivery, intubation)
  • Intraoperative parameters (time interval between diagnosis and intervention, WSES score, operative time, open abdomen, VAC)
  • After procedure (respiratory rate, heart rate, systolic blood pressure, lactate acid in blood gases, temperature, vasoactive agent delivery, intubation)
  • Empirical wide-spectrum antibiotics (type and time interval from diagnosis)

Enrollment

300 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 18 years old

  2. Signed consent from patient or authorized representative

  3. Complicated Intra-Abdominal Infection

    • Acute appendicitis with localized or diffuse peritonitis
    • Grade II or Grade III acute cholecystitis (Tokyo guidelines)
    • Visceral organ perforation with peritonitis
    • Bowel perforation after colonoscopy
    • Complicated diverticulitis (WSES classification)
    • Anastomotic leaks with abscess, localized or diffuse peritonitis

Exclusion criteria

  1. Age < 18 years old
  2. No signed consent from patient or authorized representative

Trial contacts and locations

1

Loading...

Central trial contact

Maximos Frountzas, MD MPA PhD; Konstantinos G Toutouzas, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems